DT
ALXN

Diversified Trust’s Alexion Pharmaceuticals ALXN Stock Holding History

Diversified Trust’s Portfolio ALXN Stock Details ALXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-1,141
Closed -$210K – 889
2021
Q2 		$210K Sell
1,141
-1,899
-62% -$326K 0.01% 704
2021
Q1 		$465K Buy
3,040
+600
+25% +$92.8K 0.02% 398
2020
Q4 		$381K Hold
2,440
– – 0.02% 431
2020
Q3 		$279K Buy
+2,440
New +$263K 0.01% 472
2016
Q3 		– Sell
-6,568
Closed -$767K – 376
2016
Q2 		$767K Sell
6,568
-897
-12% -$127K 0.09% 192
2016
Q1 		$1.04M Sell
7,465
-41
-0.5% -$6.02K 0.11% 167
2015
Q4 		$1.43M Sell
7,506
-929
-11% -$162K 0.15% 142
2015
Q3 		$1.32M Sell
8,435
-800
-9% -$146K 0.14% 161
2015
Q2 		$1.67M Buy
9,235
+2,285
+33% +$394K 0.16% 156
2015
Q1 		$1.2M Hold
6,950
– – 0.1% 203
2014
Q4 		$1.29M Buy
+6,950
New +$1.29M 0.12% 194
2014
Q2 		$1.27M Buy
+8,145
New +$1.29M 0.11% 220
2013
Q4 		$1.51M Sell
11,340
-800
-7% -$96K 0.15% 132
2013
Q3 		$1.41M Buy
12,140
+2,265
+23% +$249K 0.15% 144
2013
Q2 		$911K Buy
+9,875
New +$952K 0.11% 188

Other funds holding ALXN

BCI
Brinker Capital Investments Berwyn, Pennsylvania $13.1B AUM 28.37% 1-Year Est. Return
NICM
Neo Ivy Capital Management New York $434M AUM 44.19% 1-Year Est. Return
TAIM
TD Ameritrade Investment Management Omaha, Nebraska $9.4B AUM 7.2% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return
RG
Retirement Group San Diego, California $279M AUM 22.21% 1-Year Est. Return
CFO
CVA Family Office Denver, Colorado $1.1B AUM 26.6% 1-Year Est. Return
MAM
Meeder Asset Management Dublin, Ohio $1.96B AUM 48.96% 1-Year Est. Return

Diversified Trust's ALXN Position: Q3 2021 in Review

Diversified Trust sold out of Alexion Pharmaceuticals (ALXN) in Q3 2021, closing a stake of 1,141 shares — an estimated $210K sold.

Diversified Trust first reported a position in ALXN in Q2 2013 and held it in 15 quarters. The position peaked at $1.67M in Q2 2015. 7 funds tracked by Wall St. Rank hold ALXN as of Q3 2021.

  • Diversified Trust reported no remaining Alexion Pharmaceuticals position as of Q3 2021 after selling out during the quarter.
  • Diversified Trust sold 1,141 Alexion Pharmaceuticals shares in Q3 2021, an estimated $210K.
  • Diversified Trust first reported a position in Alexion Pharmaceuticals in Q2 2013 and held it in 15 quarters.
  • Diversified Trust's Alexion Pharmaceuticals position peaked at $1.67M in Q2 2015.
  • 7 funds tracked by Wall St. Rank held Alexion Pharmaceuticals as of Q3 2021.

Based on Diversified Trust's 13F filing for Q3 2021, filed 13 Jan 2022.